Hereditary cancer syndromes, somatic tumor profiling, liquid biopsy, MRD monitoring, and biomarker-driven therapy selection.

Advanced molecular diagnostics, comprehensive genomic profiling, multi-cancer early detection, and biomarker-led treatment personalization.

Advanced genetic, genomic and biomarker diagnostics for rare and undiagnosed conditions — bringing greater diagnostic clarity and supporting clinicians in defining appropriate management and treatment pathways.